semaglutide administration video FDA warns against injecting copycat Semaglutide Administration Instructions Made Easy

References 1 TakeshimaTUsuiKMoriKAsaiTYasudaKKurodaSet al

A review published in Pharmaceuticals noted that BPC-157 is known to cause pain or localized tissue reaction when injected in aqueous solution or physiological saline

Supplementing with GHRH may have the opposite effect

Reporting issues to the FDA FDA encourages health care professionals, patients, and compounders to report adverse events or quality problems with these or any medications to FDAs MedWatch Adverse Event Reporting program: Complete and submit the report online

CMS clarifies that a Part D denial is not required, but once a claim is routed to the Bridge and passes the eligibility check, it is still rejected because prior authorization is required